Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Accounts Payables: 2018-2020

Historic Accounts Payables for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $2.5 million.

  • Black Diamond Therapeutics' Accounts Payables rose 65.72% to $4.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.9 million, marking a year-over-year increase of 65.72%. This contributed to the annual value of $2.5 million for FY2020, which is 29.23% up from last year.
  • According to the latest figures from FY2020, Black Diamond Therapeutics' Accounts Payables is $2.5 million, which was up 29.23% from $2.0 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Accounts Payables ranged from a high of $2.5 million in FY2020 and a low of $416,000 during FY2018.
  • Over the past 3 years, Black Diamond Therapeutics' median Accounts Payables value was $2.0 million (recorded in 2019), while the average stood at $1.6 million.
  • Data for Black Diamond Therapeutics' Accounts Payables shows a peak YoY soared of 372.12% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Black Diamond Therapeutics' Accounts Payables stood at $416,000 in 2018, then surged by 372.12% to $2.0 million in 2019, then increased by 29.23% to $2.5 million in 2020.